Literature DB >> 32466929

Chemistry and microbial sources of curdlan with potential application and safety regulations as prebiotic in food and health.

Deepak Kumar Verma1, Alaa Kareem Niamah2, Ami R Patel3, Mamta Thakur4, Kawaljit Singh Sandhu5, Mónica L Chávez-González6, Nihir Shah3, Cristobal Noe Aguilar6.   

Abstract

Curdlan - a homopolysaccharide is comprised of glucose using β-1,3-glycosidic bond and produced by different types of microorganisms as exopolysaccharide. Curdlan gel is stable during freezing and thawing processes which find several applications in food and pharmaceutical industries. It acts as a prebiotic, stabilizer and water-holding, viscosifying and texturing agent. Additionally, curdlan gel is used as a food factor to develop the new products e.g. milk fat substitute, non-fat whipped cream, retorting (freeze-drying) process of Tofu, low-fat sausage, and low-fat hamburger. However, a great variation exists among different countries regarding the regulatory aspects of curdlan as food additives, dietary components or prebiotic substances. Therefore, the present review paper aims to discuss safety issues and the establishment of common guidelines and legislation globally, focusing on the use the applications of curdlan in the food sector including the development of noodles, meat-based products, and fat-free dairy products. This review analyzes and describes in detail the potential of curdlan as a sustainable alternative additive in health and food industries, emphasizing on the chemical composition, production, properties, and potential applications.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-malarial activity; Curdlan; Exopolysaccharides; Fat substitute; Gelling agent; Prebiotic; Stabilizer; Therapeutic effects

Mesh:

Substances:

Year:  2020        PMID: 32466929     DOI: 10.1016/j.foodres.2020.109136

Source DB:  PubMed          Journal:  Food Res Int        ISSN: 0963-9969            Impact factor:   6.475


  8 in total

1.  Curdlan production from cassava starch hydrolysates by Agrobacterium sp. DH-2.

Authors:  Jie Wan; Zhiyu Shao; Deming Jiang; Hongliang Gao; Xuexia Yang
Journal:  Bioprocess Biosyst Eng       Date:  2022-03-21       Impact factor: 3.210

2.  Ag-Contained Superabsorbent Curdlan-Chitosan Foams for Healing Wounds in a Type-2 Diabetic Mice Model.

Authors:  Elizaveta S Permyakova; Anton S Konopatsky; Konstantin I Ershov; Ksenia I Bakhareva; Natalya A Sitnikova; Dmitry V Shtansky; Anastasiya O Solovieva; Anton M Manakhov
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

Review 3.  Biomedical Applications of Bacterial Exopolysaccharides: A Review.

Authors:  Masrina Mohd Nadzir; Retno Wahyu Nurhayati; Farhana Nazira Idris; Minh Hong Nguyen
Journal:  Polymers (Basel)       Date:  2021-02-10       Impact factor: 4.329

4.  A Comprehensive Study of the Impacts of Oat β-Glucan and Bacterial Curdlan on the Activity of Commercial Starter Culture in Yogurt.

Authors:  Marek Aljewicz; Małgorzata Majcher; Beata Nalepa
Journal:  Molecules       Date:  2020-11-19       Impact factor: 4.411

5.  Dietary Curdlan Enhances Bifidobacteria and Reduces Intestinal Inflammation in Mice.

Authors:  Shafaque Rahman; Mark Davids; Patricia H P van Hamersveld; Olaf Welting; Hakim Rahaoui; Frank Schuren; Sybren L Meijer; René M van den Wijngaard; Theodorus B M Hakvoort; Wouter J de Jonge; Sigrid E M Heinsbroek
Journal:  Nutrients       Date:  2021-04-15       Impact factor: 5.717

Review 6.  Naturally-Sourced Antibacterial Polymeric Nanomaterials with Special Reference to Modified Polymer Variants.

Authors:  Marian Rofeal; Fady Abdelmalek; Alexander Steinbüchel
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

Review 7.  Probiotics in the Management of Mental and Gastrointestinal Post-COVID Symptomes.

Authors:  Igor Łoniewski; Karolina Skonieczna-Żydecka; Joanna Sołek-Pastuszka; Wojciech Marlicz
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

8.  First Report on the Streptococcusgallolyticus (S. bovis Biotype I) DSM 13808 Exopolysaccharide Structure.

Authors:  Anna Maciejewska; Czeslaw Lugowski; Jolanta Lukasiewicz
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.